GoHealth, Inc. (NASDAQ:GOCO) Receives Average Recommendation of “Hold” from Analysts

GoHealth, Inc. (NASDAQ:GOCO) has earned a consensus recommendation of “Hold” from the five research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $5.00.

Several equities analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GoHealth in a research note on Friday, April 24th. Noble Financial raised GoHealth to a “strong-buy” rating in a research note on Wednesday, April 1st. Finally, Freedom Capital lowered shares of GoHealth from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th.

GoHealth Price Performance

GOCO stock opened at $0.30 on Thursday. The company has a 50 day simple moving average of $0.50 and a 200 day simple moving average of $1.30. The stock has a market cap of $8.60 million, a price-to-earnings ratio of -0.01 and a beta of 1.19. GoHealth has a 1 year low of $0.28 and a 1 year high of $7.12.

GoHealth (NASDAQ:GOCO) last released its quarterly earnings data on Monday, May 18th. The company reported ($2.36) earnings per share for the quarter, beating the consensus estimate of ($2.40) by $0.04. GoHealth had a negative return on equity of 402.70% and a negative net margin of 189.73%.The company had revenue of $11.91 million for the quarter, compared to the consensus estimate of $16.90 million. On average, equities research analysts anticipate that GoHealth will post -9.19 EPS for the current fiscal year.

Hedge Funds Weigh In On GoHealth

Several large investors have recently added to or reduced their stakes in the business. Barclays PLC lifted its stake in GoHealth by 10.1% during the 4th quarter. Barclays PLC now owns 81,181 shares of the company’s stock valued at $175,000 after acquiring an additional 7,430 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in GoHealth by 119.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock worth $57,000 after acquiring an additional 14,388 shares during the period. Deutsche Bank AG lifted its stake in GoHealth by 150.8% in the fourth quarter. Deutsche Bank AG now owns 32,183 shares of the company’s stock valued at $69,000 after purchasing an additional 19,349 shares during the last quarter. Goldman Sachs Group Inc. purchased a new position in shares of GoHealth during the 4th quarter valued at $26,000. Finally, Geode Capital Management LLC lifted its holdings in GoHealth by 8.1% during the fourth quarter. Geode Capital Management LLC now owns 150,821 shares of the company’s stock valued at $324,000 after purchasing an additional 11,340 shares during the last quarter. Institutional investors own 24.21% of the company’s stock.

About GoHealth

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.